189 related articles for article (PubMed ID: 37947594)
1. Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients.
Morini M; Raggi F; Bartolucci M; Petretto A; Ardito M; Rossi C; Segalerba D; Garaventa A; Eva A; Cangelosi D; Bosco MC
Cells; 2023 Oct; 12(21):. PubMed ID: 37947594
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.
Degli Esposti C; Iadarola B; Maestri S; Beltrami C; Lavezzari D; Morini M; De Marco P; Erminio G; Garaventa A; Zara F; Delledonne M; Ognibene M; Pezzolo A
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915956
[TBL] [Abstract][Full Text] [Related]
3. Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
Marimpietri D; Petretto A; Raffaghello L; Pezzolo A; Gagliani C; Tacchetti C; Mauri P; Melioli G; Pistoia V
PLoS One; 2013; 8(9):e75054. PubMed ID: 24069378
[TBL] [Abstract][Full Text] [Related]
4. Exosomal hsa-piR1089 promotes proliferation and migration in neuroblastoma via targeting KEAP1.
Wang H; Shi B; Zhang X; Shen P; He Q; Yin M; Pan Y; Ma J
Pathol Res Pract; 2023 Jan; 241():154240. PubMed ID: 36436316
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic Signature.
Colletti M; Petretto A; Galardi A; Di Paolo V; Tomao L; Lavarello C; Inglese E; Bruschi M; Lopez AA; Pascucci L; Geoerger B; Peinado H; Locatelli F; Di Giannatale A
Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28722341
[TBL] [Abstract][Full Text] [Related]
6. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
7. Circulating exosomes may identify biomarkers for cows at risk for metabolic dysfunction.
Almughlliq FB; Koh YQ; Peiris HN; Vaswani K; Holland O; Meier S; Roche JR; Burke CR; Crookenden MA; Arachchige BJ; Reed S; Mitchell MD
Sci Rep; 2019 Sep; 9(1):13879. PubMed ID: 31554846
[TBL] [Abstract][Full Text] [Related]
8. NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells.
Shoae-Hassani A; Hamidieh AA; Behfar M; Mohseni R; Mortazavi-Tabatabaei SA; Asgharzadeh S
J Immunother; 2017 Sep; 40(7):265-276. PubMed ID: 28622272
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin expression has prognostic value in neuroblastoma patients.
Cangelosi D; Brignole C; Bensa V; Tamma R; Malaguti F; Carlini B; Giusto E; Calarco E; Perri P; Ribatti D; Fonseca NA; Moreira JN; Eva A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Pastorino F
EBioMedicine; 2022 Nov; 85():104300. PubMed ID: 36209521
[TBL] [Abstract][Full Text] [Related]
10. MYCN‑amplified neuroblastoma cell‑derived exosomal miR‑17‑5p promotes proliferation and migration of non‑MYCN amplified cells.
Chen W; Hao X; Yang B; Zhang Y; Sun L; Hua Y; Yang L; Yu J; Zhao J; Hou L; Lu H
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537818
[TBL] [Abstract][Full Text] [Related]
11. Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma.
Ma J; Xu M; Yin M; Hong J; Chen H; Gao Y; Xie C; Shen N; Gu S; Mo X
Front Oncol; 2019; 9():459. PubMed ID: 31249805
[TBL] [Abstract][Full Text] [Related]
12. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
Brignole C; Bensa V; Fonseca NA; Del Zotto G; Bruno S; Cruz AF; Malaguti F; Carlini B; Morandi F; Calarco E; Perri P; Moura V; Emionite L; Cilli M; De Leonardis F; Tondo A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Moreira JN; Pastorino F
J Exp Clin Cancer Res; 2021 Jun; 40(1):180. PubMed ID: 34078433
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers.
Raggi F; Bartolucci M; Cangelosi D; Rossi C; Pelassa S; Trincianti C; Petretto A; Filocamo G; Civino A; Eva A; Ravelli A; Consolaro A; Bosco MC
Front Immunol; 2023; 14():1134747. PubMed ID: 37205098
[TBL] [Abstract][Full Text] [Related]
14. Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma.
Mora J; Gerald WL; Cheung NK
Cancer Lett; 2003 Jul; 197(1-2):119-24. PubMed ID: 12880970
[TBL] [Abstract][Full Text] [Related]
15. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma.
Nozato M; Kaneko S; Nakagawara A; Komuro H
Int J Oncol; 2013 Jan; 42(1):134-40. PubMed ID: 23135478
[TBL] [Abstract][Full Text] [Related]
17. Serum-Derived Exosomes from Patients with Coronary Artery Disease Induce Endothelial Injury and Inflammation in Human Umbilical Vein Endothelial Cells.
Zhang P; Liang T; Wang X; Wu T; Xie Z; Yu Y; Yu H
Int Heart J; 2021 Mar; 62(2):396-406. PubMed ID: 33731537
[TBL] [Abstract][Full Text] [Related]
18. MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV.
Wang J; Zhang X; Yao H; Le Y; Zhou W; Li J; Lu L; Chen M; Li X
Hum Cell; 2020 Jan; 33(1):261-271. PubMed ID: 31894478
[TBL] [Abstract][Full Text] [Related]
19. Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
Chen B; Ding P; Hua Z; Qin X; Li Z
Invest New Drugs; 2021 Feb; 39(1):52-65. PubMed ID: 32772341
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
